A detailed history of Walleye Capital LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 109,655 shares of CNTX stock, worth $111,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109,655
Previous 108,376 1.18%
Holding current value
$111,848
Previous $216,000 0.93%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.79 - $2.66 $2,289 - $3,402
1,279 Added 1.18%
109,655 $214,000
Q2 2024

Aug 14, 2024

BUY
$1.24 - $2.19 $134,386 - $237,343
108,376 New
108,376 $216,000

Others Institutions Holding CNTX

About Context Therapeutics Inc.


  • Ticker CNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,966,100
  • Market Cap $16.3M
  • Description
  • Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...
More about CNTX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.